Se Joo Kim and Chan-Hyung Kim untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 2002;7:44-55. 70. Yoo SW, Kim SJ, Kim CH. Association between obses- sive-compulsive disorder and dopamine transporter gene polymorphism. Psychiatry Invest 2006;3:72-7. 71. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expres- sion. Pharmacogenomics J 2001;1:152-6. 72. van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, et al. Multiple dopamine D4 receptor variants in the human population. Nature 1992;358:149-52. 73. Billett EA, Richter MA, Sam F, Swinson RP, Dai XY, King N, et al. Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatr Genet 1998; 8:163-9. 74. Millet B, Chabane N, Delorme R, Leboyer M, Leroy S, Poirier MF, et al. Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2003;116:55-9. 75. Hemmings SM, Kinnear CJ, Lochner C, Niehaus DJ, Knowles JA, Moolman-Smook JC, et al. Early- versus late-onset obsessive-compulsive disorder: investigating genetic and clinical correlates. Psychiatry Res 2004;128: 175-82. 76. Kim SJ, Yoo SW, Nam YY, Lee HS, Kim CH. Asso- ciation between obsessive-compulsive disorder and dopamine receptor D4. Korean J Psychopharmacol 2005;16:513-20. 77. Denys D, Van Nieuwerburgh F, Deforce D, Westenberg H. Association between the dopamine D(2) receptor TaqI A2 allele and low activity COMT allele with ob- sessive-compulsive disorder in males. Eur Neuropsy- chopharmacol 2006;16:446-50. 78. Catalano M, Sciuto G, Di Bella D, Novelli E, Nobile M, Bellodi L. Lack of association between obsessive- com- pulsive disorder and the dopamine D3 receptor gene: some preliminary considerations. Am J Med Genet 1994;54:253-5. 79. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltrans- ferase pharmacogenetics: description of a functional polymorphism and its potential application to neuro- psychiatric disorders. Pharmacogenetics 1996;6:243-50. 80. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995;34:4202-10. 81. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A 1997;94:4572-5. 82. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Yonsei Med J Vol. 47, No. 4, 2006 Malinova L, Goldberg P, et al. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive- compulsive disorder. Biol Psychiatry 1999;45:1178-89. 83. Schindler KM, Richter MA, Kennedy JL, Pato MT, Pato CN. Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am J Med Genet 2000;96:721-4. 84. Niehaus DJ, Kinnear CJ, Corfield VA, du Toit PL, van Kradenburg J, Moolman-Smook JC, et al. Association between a catechol-o-methyltransferase polymorphism and obsessive-compulsive disorder in the Afrikaner population. J Affect Disord 2001;65:61-5. 85. Erdal ME, Tot S, Yazici K, Yazici A, Herken H, Erdem P, et al. Lack of association of catechol-O-methyltrans- ferase gene polymorphism in obsessive-compulsive disorder. Depress Anxiety 2003;18:41-5. 86. Ohara K, Nagai M, Suzuki Y, Ochiai M, Ohara K. No association between anxiety disorders and catechol-O- methyltransferase polymorphism. Psychiatry Res 1998; 80:145-8. 87. Hotamisligil GS, Breakefield XO. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 1991;49:383-92. 88. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998;103:273-9. 89. Camarena B, Rinetti G, Cruz C, Gomez A, de La Fuente JR, Nicolini H. Additional evidence that genetic varia- tion of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. Am J Med Genet 2001; 105:279-82. 90. Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obses- sive-compulsive disorder: a preliminary study. Psycho- pharmacology (Berl) 2004;174:530-8. 91. Delorme R, Krebs MO, Chabane N, Roy I, Millet B, Mouren-Simeoni MC, et al. Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymor- phisms in patients with obsessive compulsive disorder. Neuroreport 2004;15:699-702. 92. Zai G, Arnold P, Burroughs E, Barr CL, Richter MA, Kennedy JL. Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a suscepti- bility factor in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2005;134:25-9. 93. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly asso- ciated with obsessive-compulsive disorder. Am J Hum Genet 2003;73:370-6. 94. Miguel EC, Leckman JF, Rauch S, do Rosario-Campos MC, Hounie AG, Mercadante MT, et al. Obsessive- compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 2005;10:258-75.